Online + Download (unlimited users)

 

Mass spectrometry is transitioning from a specialized analytical technology into a mainstream clinical diagnostics platform, creating one of the most significant growth opportunities in laboratory medicine.

For much of its history, mass spectrometry (MS) was confined to research institutions, pharmaceutical laboratories, and specialized reference testing facilities. Its unmatched analytical sensitivity and specificity made it…

The 2026 SDi Global Assessment Datastream is only available to those who have purchased The 2026 Global Assessment Report: The Analytical and Life Science Instrumentation Industry.

The world runs on roughly 150 billion diagnostic tests a year—and that number is climbing faster than the revenue behind it. IVD Test Procedure Volumes, 8th Edition quantifies that divergence with precision, tracking global procedure volumes segment by segment and region by region as the diagnostics industry completes its transition out of the pandemic era.…

SDi’s Market Landscape: Sequencing report analyzes the sequencing market’s sizing, five-year forecasts, vendor shares, and the litigation and regulatory trends shaping Illumina, Oxford Nanopore, PacBio, and emerging entrants.

The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…

IMV’s 2026 Oncology in Diagnostic Imaging Market Outlook Report covers procedure volumes, installed base, manufacturer share, purchase plans, and AI adoption across eight modalities, based on a survey of 215 U.S. imaging professionals conducted through June 2026.

Kalorama’s 105-page clinical proteomics report sizes the market by technology and region through 2030, covering mass spectrometry, high-plex affinity assays, digital immunoassays, and spatial proteomics, with company profiles of 16 vendors and analysis of deals, approvals, and trends from 2021 to 2026.

SDi’s 2026 sample preparation report covers nucleic acid prep, extraction techniques, and preparative chromatography across 15-plus segments, with market sizing, five-year forecasts through 2030, vendor market shares, and segmentation by sector, region, and application.

SDi’s 2026 report covers the global analytical and life science instrumentation service market across 10 technology segments, five service categories, and key end-market sectors, with five-year forecasts through 2030 and insights from 323 laboratory professionals.

Now in its 11th edition, Kalorama Information’s flagship review of clinical laboratory services gives decision-makers a rigorous, independent read on where diagnostic testing revenue sits today and where it is heading. Built on a 2025 base year, with historical data spanning 2020–2024 and forecasts running through 2030, the report is the reference stakeholders use to…

IMV’s 2026 C-arm Market Outlook Report delivers primary research on the fixed and portable C-arm market across U.S. hospitals — covering installed base by department, procedure volume and mix, manufacturer market share, purchase plans for the next three years, and site operations characteristics including staffing trends and service support arrangements. Based on surveys conducted through…

Kalorama’s 30-Country IVD Market Atlas sizes and forecasts the in vitro diagnostics market across 30 key countries and 18 segments, with five-year projections through 2030 and country-level revenue data updated through June 2026.